Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TechnologyAdvice

- PMLiVE

FDA approves Olysio/Sovaldi combination in hep C

Janssen drug recommended for use along with Gilead’s blockbuster

- PMLiVE

UCB to sell its US generics business for $1.5bn

Advent International and Avista Capital Partners will take control of Kremers Urban Pharmaceuticals

Avoiding pharma’s Death Valley

For life science companies, evolving is getting harder, not easier

Pharma deals during October 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for October 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

EISAI

Eisai “speechless” as G-BA denies price premium for Fycompa

But company has better news on cancer drug Halaven

Shire Basingstoke

Shire drawn into Luxembourg tax haven exposé

Firm is one of 340 companies identified in report by ICIJ

Novartis building

Novartis faces FDA rejection for myeloma drug

Concerns over toxicity of panobinostat

- PMLiVE

Perrigo expands consumer health with €3.6bn Omega purchase

Follows takeover of Elan last year

Hamell Communications adds to team

Comms agency has steadily expanded team this year

- PMLiVE

Saatchi & Saatchi expands team

Includes two new associate creative directors

- PMLiVE

Nexium windfall lifts AZ in third quarter

Still to feel effects of generic competition

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links